Company profile for MEDSIR

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

MEDSIR is an international private company that was founded by scientific experts in oncology back in 2012. They are dedicated to the design and management of strategic clinical trials in oncology, from the initial study conception to the final publication of results. The company act as the link between our international network of brilliant oncology investigators and the parties (Pharma Companies, Biotechs, Public Institution...
MEDSIR is an international private company that was founded by scientific experts in oncology back in 2012. They are dedicated to the design and management of strategic clinical trials in oncology, from the initial study conception to the final publication of results. The company act as the link between our international network of brilliant oncology investigators and the parties (Pharma Companies, Biotechs, Public Institutions, etc.) interested in providing funding for their clinical research ideas.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Spain
Address
Address
MEDSIR BCN Torre Glòries - Planta 27, Avinguda Diagonal, 211, 08018 Barcelona
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20251212609556/en/Natera-and-MEDSIR-to-Collaborate-on-the-MiRaDoR-Trial-in-Breast-Cancer

BUSINESSWIRE
12 Dec 2025

https://www.prnewswire.com/news-releases/the-pherguide-study-demonstrates-the-utility-of-circulating-tumor-dna-for-the-early-detection-and-real-time-monitoring-of-localized-her2-breast-cancer-302639299.html

PR NEWSWIRE
11 Dec 2025

https://www.fiercebiotech.com/cro/spanish-oncology-research-org-infuses-ai-breast-cancer-trials

FIERCE BIOTECH
07 Oct 2025

https://www.businesswire.com/news/home/20251002282761/en/MEDSIR-and-Ataraxis-AI-Launch-Research-Collaboration-to-Evaluate-AI-Powered-Platform-as-a-Predictive-Tool-in-Breast-Cancer-Randomized-Clinical-Trials

BUSINESSWIRE
02 Oct 2025

https://www.businesswire.com/news/home/20250604087994/en/New-Potential-Treatment-Strategy-for-Brain-Metastases-and-Leptomeningeal-Disease-HER3-DXd-Shows-Promising-Results-in-the-Phase-II-TUXEDO-3-Study-for-Patients-With-Limited-Therapeutic-Options

BUSINESSWIRE
04 Jun 2025

https://www.prnewswire.com/news-releases/her3-dxd-shows-promising-results-in-the-phase-ii-tuxedo-3-study-for-patients-with-limited-therapeutic-options-302469916.html

PR NEWSWIRE
30 May 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty